RxDoctor Payments Data

Herndon Jeansonne, APRN

Family · Cottonport, LANPI 1114002698

Payments from drug & device makers

$263in general payments, 2019–2025

Across 12 payments — averaging $21.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$73
  • Cardiovascular Systems Inc.$58
  • Lilly USA, LLC$46
  • Xeris Pharmaceuticals, Inc.$23
  • GSK$18
  • Merck$18
  • plus $27 from 2 others

What the payments were for

  • Food & beverage$263100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$263 in reported general payments places this provider in the 35th percentile of 3,610 family providers in Louisiana.

See all family providers in Louisiana

Medicare billing

Part B allowed, 2024
$173
Medicare patients
16
Services billed
46

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide91$96,686
TrulicityDulaglutide80$88,570
JardianceEmpagliflozin69$68,431
JanuviaSitagliptin Phosphate47$41,580
EliquisApixaban20$25,517
TradjentaLinagliptin22$19,819
OzempicSemaglutide18$17,580
FarxigaDapagliflozin Propanediol17$16,035
Trelegy ElliptaFluticasone/Umeclidin/Vilanter18$12,045
LinzessLinaclotide17$10,579
EntrestoSacubitril/Valsartan12$9,999
Atrovent HfaIpratropium Bromide14$7,726
Gabapentin173$2,657
Albuterol Sulfate HfaAlbuterol Sulfate81$2,648
Atorvastatin Calcium215$2,044

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$46$185,256171 claims
MerckJanuvia$18$41,58047 claims
GSKTrelegy Ellipta$18$12,04518 claims
AbbVieLinzess$73$10,57917 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 3,610 family providers in Louisiana.

Other family in Cottonport

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →